Open access · US-GOV via ClinicalTrials.gov Clinical trial

Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)

Authors not listed

OHSU Knight Cancer Institute · 2024

Dysbiosis Exercise Human Randomized controlled trial

Abstract

This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and obesity can lead to a decrease in quality of life and an increased risk of recurrent falls. Using iLIVE may improve obesity and frailty in men with prostate cancer who receive ADT.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-16 MST

Cite this

APA

Anonymous. (2024). Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE). <em>OHSU Knight Cancer Institute</em>. https://clinicaltrials.gov/study/NCT06011499

Vancouver

Anonymous. Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE). OHSU Knight Cancer Institute. 2024.

BibTeX

@misc{anon2024Intern, title = {Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)}, author = {Anonymous}, journal = {OHSU Knight Cancer Institute}, year = {2024}, }